NCT00772525View on ClinicalTrials.gov

Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Multiple SclerosisOptic NerveNeuritis

Interventions

DRUG

Nerispirdine

"form: tablet~Route: oral"

DRUG

Placebo

"form: tablet~Route: oral"

Trial Locations (1)

08807

Sanofi-Aventis Administrave Office, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY